These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7339248)

  • 1. Mechanisms of estrogen and antiestrogen action in mammary cancer.
    Katzenellenbogen BS; Rorke EA; Eckert RL
    J Steroid Biochem; 1981 Dec; 15():219-29. PubMed ID: 7339248
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors.
    Turcot-Lemay L; Kelly PA
    Cancer Res; 1980 Sep; 40(9):3232-40. PubMed ID: 6253058
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384.
    Nishino Y; Schneider MR; Michna H
    J Cancer Res Clin Oncol; 1994; 120(5):298-302. PubMed ID: 8126059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and progesterone receptor proteins in breast cancer.
    Edwards DP; Chamness GC; McGuire WL
    Biochim Biophys Acta; 1979 Dec; 560(4):457-86. PubMed ID: 391286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of new drugs for endocrine tumour chemotherapy.
    von Angerer E
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():147-53. PubMed ID: 6547370
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization and estrogen stimulation of cytoplasmic progesterone receptor in the ovarian-dependent MXT-3590 mammary tumor line.
    Watson CS; Medina D; Clark JH
    Cancer Res; 1979 Oct; 39(10):4098-104. PubMed ID: 476646
    [No Abstract]   [Full Text] [Related]  

  • 8. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
    Ip MM; Milholland RJ; Rosen F; Kim U
    Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a functional estrogen receptor always required for progesterone receptor induction in breast cancer?
    Horwitz KB
    J Steroid Biochem; 1981 Dec; 15():209-17. PubMed ID: 7339247
    [No Abstract]   [Full Text] [Related]  

  • 10. A new triphenylethylene derivative, TAT-59; hormone receptors; insulin-like growth factor 1; and growth suppression of hormone-dependent MCF-7 tumors in athymic mice.
    Iino Y; Takai Y; Ando T; Ohwada S; Yokoe T; Sugamata N; Takei H; Horiguchi J; Iijima K; Morishita Y
    Cancer Chemother Pharmacol; 1994; 34(5):372-6. PubMed ID: 8070003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory interrelationships for insulin and estrogen action in mammary tumors.
    Hilf R; Hissin PJ; Shafie SM
    Cancer Res; 1978 Nov; 38(11 Pt 2):4076-85. PubMed ID: 100214
    [No Abstract]   [Full Text] [Related]  

  • 12. [N-(4-hydroxyphenyl)-N-(1,1,1-trifluor-2-propyl)-4-hydroxyben zamide: synthesis and pharmacologic evaluation of a new antiestrogen].
    Hartmann RW; vom Orde HD; Heindl A; Schönenberger H
    Arch Pharm (Weinheim); 1988 Aug; 321(8):497-501. PubMed ID: 3223808
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of high-dose estrogen on growth and steroid receptor activity in DMBA-induced mammary tumors and uteri of rats.
    Gabriel BW; Sahai G; Anderson WA
    J Toxicol Environ Health; 1983 Mar; 11(3):437-54. PubMed ID: 6341612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone and progesterone receptors in experimental breast cancer.
    Horwitz KB; McGuire WL
    Cancer Res; 1977 Jun; 37(6):1733-8. PubMed ID: 404036
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiological and pharmacological effects of estrogens in breast cancer.
    Leclercq G; Heuson JC
    Biochim Biophys Acta; 1979 Dec; 560(4):427-55. PubMed ID: 391285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonistic action between cyclic adenosine 3':5'-monophosphate and estrogen in rat mammary tumor growth control.
    Cho-Chung YS
    Cancer Res; 1978 Nov; 38(11 Pt 2):4071-5. PubMed ID: 212186
    [No Abstract]   [Full Text] [Related]  

  • 17. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
    Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
    Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic action between cyclic AMP and estrogen in phosphorylation of mammary tumor nuclear proteins.
    Cho-chung YS; Doud FJ
    Cancer Lett; 1978 Oct; 5(4):219-24. PubMed ID: 210929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
    Gottardis MM; Jordan VC
    Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of the antioestrogen trioxifene against N-Nitrosomethylurea-induced rat mammary carcinomas.
    Rose DP; Fischer AH; Jordan VC
    Eur J Cancer Clin Oncol; 1981 Aug; 17(8):893-8. PubMed ID: 7198978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.